Nephrogenic Systemic Fibrosis, also known as nephrogenic fibrosing dermopathy, is related to systemic scleroderma and scleroderma, familial progressive, and has symptoms including exanthema and pruritus. An important gene associated with Nephrogenic Systemic Fibrosis is TGFB1 (Transforming Growth Factor Beta 1), and among its related pathways/superpathways are ERK Signaling and MIF Mediated Glucocorticoid Regulation. The drugs Pharmaceutical Solutions and Protein Kinase Inhibitors have been mentioned in the context of this disorder. Affiliated tissues include skin and kidney, and related phenotypes are homeostasis/metabolism and growth/size/body region